SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-011140
Filing Date
2016-03-15
Accepted
2016-03-15 08:56:33
Documents
69
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2227746z10-k.htm 10-K 1201287
2 EX-23.1 a2227746zex-23_1.htm EX-23.1 6602
3 EX-31.1 a2227746zex-31_1.htm EX-31.1 7896
4 EX-31.2 a2227746zex-31_2.htm EX-31.2 7941
5 EX-32.1 a2227746zex-32_1.htm EX-32.1 4847
12 G814392.JPG g814392.jpg GRAPHIC 78515
  Complete submission text file 0001047469-16-011140.txt   6855702

Data Files

Seq Description Document Type Size
6 EX-101.INS snta-20151231.xml EX-101.INS 1775385
7 EX-101.SCH snta-20151231.xsd EX-101.SCH 44385
8 EX-101.CAL snta-20151231_cal.xml EX-101.CAL 47547
9 EX-101.LAB snta-20151231_lab.xml EX-101.LAB 463866
10 EX-101.PRE snta-20151231_pre.xml EX-101.PRE 324328
11 EX-101.DEF snta-20151231_def.xml EX-101.DEF 161720
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 161505656
SIC: 2834 Pharmaceutical Preparations